Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
The effect of cinnamon supplementation on ovulation induction in women with polycystic ovary syndrome, Jeddah 2018: Randomized Double-Blind Placebo-controlled trial	King Abdulaziz University (Jeddah)	Ongoing	Cinnamon	3	100-18	King Abdulaziz University Hospital (Jeddah)
Apixaban in Patients with Left Ventricular Thrombus, CLEAN-LV Study	Saud Al Babtain Cardiac Center	Ongoing	Apixaban	4	2018-08	Saud Al-Babtain Cardiac Center (Dammam)N/A
"AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting."	Bayer	Ongoing	Aflibercept	4	191 57	King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh)
An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD	Hikma Pharmaceuticals	Ongoing	Remsima	4	RMS-KSA-20	King Abdulaziz University Hospital (Jeddah)
Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition.	MEDIS Laboratories	Ongoing	Enoxa / Enoxaparin	BE	21-2017 v.02	Saudi Ajal
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma	SWOG (Southwest Oncology Group)	Ongoing	Ibrutinib	3	A051301	King Faisal Specialist Hospital and Research Center (Riyadh)
OPEN LABEL, RANDOMIZED, SINGLE SITE CLINICAL TRIAL TO COMPARE THE SAFETY & EFFICACY OF HERBAL MELANIN EXTRACTED FROM NIGELLA SATIVA SEEDS VS STANDARD OF CARE TREATMENT IN TREATING GASTRITIS PATIENTS	KAIMRC	Rejected	Melanole NIGELLA SATIVA	2	RC15/152/R	N/A
ATOS study_A 12–month prospective observational study assessing the real-world clinical effectiveness, safety and health-economic benefits of Toujeo® initiation after oral antidiabetic drug failure in insulin-naïve patients with type 2 diabetes mellitus	SANOFI	Ongoing	TOUJEO	4	OBS14708	King Abdulaziz University Hospital (Jeddah), Dr. Ghassan N. Pharaon General Hospital (Jeddah), Dallah Hospital (Riyadh), Alzafer Hospital (Najran), Dr. Bakhsh Hospital (Jeddah), Saudi German Hospital (Jeddah), Arrawdha General Hospital (Dammam), Almana Hospital (Jubail), Almouwasat Hospital (Dammam), Specialized Medical Center (Riyadh)
"A 12-week, multicenter, randomized, double-blind, placebo-controlledstudy to assess the efficacy and safety of QAW039 when added tostandard-of-care asthma therapy in patients with uncontrolled asthma"	Novartis	Ongoing	QAW039/Fevipiprant	3	CQAW039A2316	King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah)
"A 2-treatment period, randomized, placebo-controlled,multicenter parallel-group study to assess the safety ofQAW039 when added to existing asthma therapy in GINAsteps 3, 4 and 5 patients with uncontrolled asthma"	Novartis	Ongoing	QAW039/Fevipiprant	3	CQAW039A2315	King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah)